Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-26

Clinical Trial Update: Effect of Duloxetine on Opioid Use After Total Knee Arthroplasty [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated whether duloxetine reduces opioid use after total knee arthroplasty; results were posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Joint Disease, Pain, Acute | Phase 4 | Status: COMPLETED | Results posted: 2022-04-26